310 related articles for article (PubMed ID: 23438974)
1. APOL1 variants and kidney disease in people of recent African ancestry.
Genovese G; Friedman DJ; Pollak MR
Nat Rev Nephrol; 2013 Apr; 9(4):240-4. PubMed ID: 23438974
[TBL] [Abstract][Full Text] [Related]
2. Population genetics of chronic kidney disease: the evolving story of APOL1.
Wasser WG; Tzur S; Wolday D; Adu D; Baumstein D; Rosset S; Skorecki K
J Nephrol; 2012; 25(5):603-18. PubMed ID: 22878977
[TBL] [Abstract][Full Text] [Related]
3. The biology of APOL1 with insights into the association between APOL1 variants and chronic kidney disease.
Madhavan SM; O'Toole JF
Clin Exp Nephrol; 2014 Apr; 18(2):238-42. PubMed ID: 24233469
[TBL] [Abstract][Full Text] [Related]
4. Identifying Darwinian selection acting on different human APOL1 variants among diverse African populations.
Ko WY; Rajan P; Gomez F; Scheinfeldt L; An P; Winkler CA; Froment A; Nyambo TB; Omar SA; Wambebe C; Ranciaro A; Hirbo JB; Tishkoff SA
Am J Hum Genet; 2013 Jul; 93(1):54-66. PubMed ID: 23768513
[TBL] [Abstract][Full Text] [Related]
5. APOL1 genetic variants, chronic kidney diseases and hypertension in mixed ancestry South Africans.
Matsha TE; Kengne AP; Masconi KL; Yako YY; Erasmus RT
BMC Genet; 2015 Jun; 16():69. PubMed ID: 26112018
[TBL] [Abstract][Full Text] [Related]
6. Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene.
Tzur S; Rosset S; Shemer R; Yudkovsky G; Selig S; Tarekegn A; Bekele E; Bradman N; Wasser WG; Behar DM; Skorecki K
Hum Genet; 2010 Sep; 128(3):345-50. PubMed ID: 20635188
[TBL] [Abstract][Full Text] [Related]
7. Genetic variation in APOL1 and MYH9 genes is associated with chronic kidney disease among Nigerians.
Tayo BO; Kramer H; Salako BL; Gottesman O; McKenzie CA; Ogunniyi A; Bottinger EP; Cooper RS
Int Urol Nephrol; 2013 Apr; 45(2):485-94. PubMed ID: 22956460
[TBL] [Abstract][Full Text] [Related]
8. APOL1 kidney risk alleles: population genetics and disease associations.
Limou S; Nelson GW; Kopp JB; Winkler CA
Adv Chronic Kidney Dis; 2014 Sep; 21(5):426-33. PubMed ID: 25168832
[TBL] [Abstract][Full Text] [Related]
9. Effect of Genetic African Ancestry on eGFR and Kidney Disease.
Udler MS; Nadkarni GN; Belbin G; Lotay V; Wyatt C; Gottesman O; Bottinger EP; Kenny EE; Peter I
J Am Soc Nephrol; 2015 Jul; 26(7):1682-92. PubMed ID: 25349204
[TBL] [Abstract][Full Text] [Related]
10. Increased burden of cardiovascular disease in carriers of APOL1 genetic variants.
Ito K; Bick AG; Flannick J; Friedman DJ; Genovese G; Parfenov MG; Depalma SR; Gupta N; Gabriel SB; Taylor HA; Fox ER; Newton-Cheh C; Kathiresan S; Hirschhorn JN; Altshuler DM; Pollak MR; Wilson JG; Seidman JG; Seidman C
Circ Res; 2014 Feb; 114(5):845-50. PubMed ID: 24379297
[TBL] [Abstract][Full Text] [Related]
11. The Apolipoprotein L1 Gene and Cardiovascular Disease.
Robinson TW; Freedman BI
Methodist Debakey Cardiovasc J; 2016; 12(4 Suppl):2-5. PubMed ID: 28298955
[TBL] [Abstract][Full Text] [Related]
12. Association of APOL1 variants with mild kidney disease in the first-degree relatives of African American patients with non-diabetic end-stage renal disease.
Freedman BI; Langefeld CD; Turner J; Núñez M; High KP; Spainhour M; Hicks PJ; Bowden DW; Reeves-Daniel AM; Murea M; Rocco MV; Divers J
Kidney Int; 2012 Oct; 82(7):805-11. PubMed ID: 22695330
[TBL] [Abstract][Full Text] [Related]
13.
Chen TK; Appel LJ; Grams ME; Tin A; Choi MJ; Lipkowitz MS; Winkler CA; Estrella MM
Arterioscler Thromb Vasc Biol; 2017 Sep; 37(9):1765-1769. PubMed ID: 28572159
[TBL] [Abstract][Full Text] [Related]
14. APOL1 risk variants, race, and progression of chronic kidney disease.
Parsa A; Kao WH; Xie D; Astor BC; Li M; Hsu CY; Feldman HI; Parekh RS; Kusek JW; Greene TH; Fink JC; Anderson AH; Choi MJ; Wright JT; Lash JP; Freedman BI; Ojo A; Winkler CA; Raj DS; Kopp JB; He J; Jensvold NG; Tao K; Lipkowitz MS; Appel LJ; ;
N Engl J Med; 2013 Dec; 369(23):2183-96. PubMed ID: 24206458
[TBL] [Abstract][Full Text] [Related]
15. APOL1 variants associate with increased risk of CKD among African Americans.
Foster MC; Coresh J; Fornage M; Astor BC; Grams M; Franceschini N; Boerwinkle E; Parekh RS; Kao WH
J Am Soc Nephrol; 2013 Sep; 24(9):1484-91. PubMed ID: 23766536
[TBL] [Abstract][Full Text] [Related]
16. The apolipoprotein L1 (APOL1) gene and nondiabetic nephropathy in African Americans.
Freedman BI; Kopp JB; Langefeld CD; Genovese G; Friedman DJ; Nelson GW; Winkler CA; Bowden DW; Pollak MR
J Am Soc Nephrol; 2010 Sep; 21(9):1422-6. PubMed ID: 20688934
[TBL] [Abstract][Full Text] [Related]
17. High population frequencies of APOL1 risk variants are associated with increased prevalence of non-diabetic chronic kidney disease in the Igbo people from south-eastern Nigeria.
Ulasi II; Tzur S; Wasser WG; Shemer R; Kruzel E; Feigin E; Ijoma CK; Onodugo OD; Okoye JU; Arodiwe EB; Ifebunandu NA; Chukwuka CJ; Onyedum CC; Ijoma UN; Nna E; Onuigbo M; Rosset S; Skorecki K
Nephron Clin Pract; 2013; 123(1-2):123-8. PubMed ID: 23860441
[TBL] [Abstract][Full Text] [Related]
18. Re-Sequencing of the APOL1-APOL4 and MYH9 Gene Regions in African Americans Does Not Identify Additional Risks for CKD Progression.
Hawkins GA; Friedman DJ; Lu L; McWilliams DR; Chou JW; Sajuthi S; Divers J; Parekh RS; Li M; Genovese G; Pollack MR; Hicks PJ; Bowden DW; Ma L; Freedman BI; Langefeld CD
Am J Nephrol; 2015; 42(2):99-106. PubMed ID: 26343748
[TBL] [Abstract][Full Text] [Related]
19. Examination of Potential Modifiers of the Association of APOL1 Alleles with CKD Progression.
Chen TK; Choi MJ; Kao WH; Astor BC; Scialla JJ; Appel LJ; Li L; Lipkowitz MS; Wolf M; Parekh RS; Winkler CA; Estrella MM; Crews DC
Clin J Am Soc Nephrol; 2015 Dec; 10(12):2128-35. PubMed ID: 26430087
[TBL] [Abstract][Full Text] [Related]
20. Copy Number Variation at the APOL1 Locus.
Ruchi R; Genovese G; Lee J; Charoonratana VT; Bernhardy AJ; Alper SL; Kopp JB; Thadhani R; Friedman DJ; Pollak MR
PLoS One; 2015; 10(5):e0125410. PubMed ID: 25933006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
